Background Neuraminidase inhibitors were widely used during the 2009–10 influenza A
H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We …

Annual seasonal influenza epidemics of variable severity result in significant morbidity and
mortality in the United States (US) and worldwide. In temperate climate countries, including …

In light of the frequency, morbidity and mortality associated with influenza-associated
aspergillosis in the ICU, a high awareness of the diagnosis and prompt initiation of …

Purpose To determine clinical predictors associated with corticosteroid administration and
its association with ICU mortality in critically ill patients with severe influenza pneumonia …

Background Co-infection is frequently seen in critically ill patients with influenza, although
the exact rate is unknown. We determined the rate of co-infection, the risk factors and the …

Background. Neuraminidase inhibitor (NAI) antiviral drugs can shorten the duration of
uncomplicated influenza when administered early (< 48 hours after illness onset) to …

Die vorliegende Leitlinie umfasst ein neues und aktualisiertes Konzept der Behandlung und
Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die …

Purpose While most influenza patients have a self-limited respiratory illness, 5–10% of
hospitalized patients develop severe disease requiring ICU admission. The aim of this study …

Influenza causes annual epidemics of respiratory viral infections are associated with
significant morbidity and mortality. Influenza vaccines have been shown to reduce the risk of …

Critically ill patients are admitted to an intensive care unit (ICU) for multiple reasons. In this
study, we aim to analyze the current evidence and findings associated with influenza and …